| name | design-perinatal-mental-health-plan |
| description | Use when addressing mental health during pregnancy or postpartum — e.g., "depression during pregnancy", "EPDS screening", "perinatal anxiety", "postpartum depression risk", "antidepressants while pregnant" |
| source | Cox et al. BJOG 1987 (EPDS); ACOG Committee Opinion 757 (2018); NICE Antenatal/Postnatal Mental Health NG192 (2020); SAMHSA Perinatal Mental Health 2020 |
| tags | ["pregnancy","mental-health","perinatal-depression","EPDS","anxiety","postpartum","health"] |
| verified | true |
Design Perinatal Mental Health Plan
Screen, identify, and create a care pathway for perinatal depression and anxiety.
Why This Is Best Practice
Adopted by: ACOG, NICE, USPSTF — all recommend systematic screening for perinatal depression at prenatal and postpartum visits.
Impact: Perinatal depression affects 10–15% of pregnant and 15–20% of postpartum women (ACOG 2018). Untreated, it increases preterm birth by 40%, low birth weight by 30%, and suicide risk — the leading cause of maternal death in the first postpartum year (MBRRACE-UK). Treatment reduces symptom burden by 50–70% (CBT + SSRI vs. placebo, Sockol meta-analysis 2011).
Why best: Perinatal depression is underdiagnosed because both patients and providers attribute symptoms to "normal pregnancy." Systematic screening with a validated tool closes this gap.
Steps
- Screen with EPDS at every trimester and 6-week postpartum visit:
- Edinburgh Postnatal Depression Scale (EPDS) — 10 questions, 5 minutes, validated across cultures
- Scoring: 0–9 = low risk; 10–12 = monitor closely; ≥13 = warrants clinical assessment
- Question 10 (self-harm ideation) scored separately — any score >0 requires same-day assessment
- Also screen for anxiety — EPDS anxiety subscale (items 3, 4, 5); GAD-7 is an alternative.
- If EPDS ≥13 or clinical concern:
- Validate: "These feelings are common and treatable — this isn't your fault."
- Refer to perinatal mental health specialist or OB-affiliated social worker
- For mild–moderate: CBT is first-line (CBT equally effective as medication for mild/moderate PND)
- For moderate–severe: SSRIs are safe in pregnancy; sertraline is most studied with lowest placental transfer
- Risk factors — increase monitoring frequency:
- Personal or family history of depression/anxiety, prior postpartum depression, poor social support, intimate partner violence, pregnancy loss history, NICU admission
- Safety planning: if any suicidal ideation, complete a formal safety plan with provider before leaving visit.
- Partner/support person: screen partner with EPDS — 10% of partners experience perinatal depression.
Rules
- Never dismiss symptoms as "just hormones" — perinatal depression is a medical condition with effective treatments.
- SSRIs in pregnancy are not teratogenic — the risk of untreated depression exceeds SSRI risk for most patients (ACOG 2018).
- Benzodiazepines in pregnancy require careful risk-benefit discussion; avoid long-term use.
Examples
EPDS = 14 at 28-week visit: Provider validates, refers to perinatal CBT therapist, schedules 2-week follow-up EPDS, discusses sertraline option if no improvement in 4 weeks.
History of PPD: Start EPDS monthly from 28 weeks; create postpartum mental health plan before delivery including lactation-compatible medication option.
Common Mistakes
- Only screening postpartum — depression onset during pregnancy predicts postpartum episodes; screen in all trimesters.
- Conflating "baby blues" (days 2–5 postpartum, self-resolving) with PPD (onset weeks 1–12, persistent, requires treatment).
- Stopping antidepressants abruptly without medical guidance — discontinuation syndrome is serious and relapse is common.
Health Disclaimer: Perinatal mental health screening is not a diagnosis. EPDS results should be reviewed by a qualified healthcare provider. If you are experiencing suicidal thoughts, call 988 (Suicide & Crisis Lifeline) or go to the nearest emergency room.
